Literature DB >> 29853266

Myocarditis associated with influenza infection in five children.

Kubra Aykac1, Yasemin Ozsurekci2, Pinar Kahyaoglu3, Sevgen T Basaranoglu2, Ilker Ertugrul4, Alpaslan Alp5, Ali B Cengiz2, Ates Kara2, Mehmet Ceyhan2.   

Abstract

BACKGROUND: Myocarditis is an inflammatory condition located mainly in the myocardium. It is caused by a variety of bacterial and viral infections. Influenza is one of the most common relevant viruses that cause myocarditis.
OBJECTIVES: We attempted to share our experiences about clinical and laboratory findings, cardiac evaluation, and treatment of children with influenza myocarditis.
METHODS: This retrospective study was performed by the Department of Pediatric Infectious Diseases at the Faculty of Medicine, Hacettepe University in Turkey. The medical records of patients diagnosed with myocarditis associated with an influenza infection between January 2014 and January 2017 were systematically reviewed.
RESULTS: Vaccination seems likely to be an important protection strategy for both influenza infections and complications.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Children; Influenza; Myocarditis

Mesh:

Substances:

Year:  2018        PMID: 29853266     DOI: 10.1016/j.jiph.2018.05.003

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  2 in total

Review 1.  Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?

Authors:  Susanna Esposito; Caterina Caminiti; Rosanna Giordano; Alberto Argentiero; Greta Ramundo; Nicola Principi
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

2.  Outcome predictors of influenza for hospitalization and mortality in children.

Authors:  Yasemin Ozsurekci; Kubra Aykac; Fatma Bal; Cihangul Bayhan; Sevgen T Basaranoglu; Alpaslan Alp; Ali Bulent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  J Med Virol       Date:  2021-02-09       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.